查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1642421

治疗性血球分离市场 - 全球产业分析、规模、占有率、成长、趋势及预测（2032年）

Therapeutic Apheresis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 178 Pages | 商品交期: 2-5个工作天内

价格
简介目录

受医疗技术进步和精准医疗日益整合的推动，治疗性血球分离市场规模预计将大幅扩大。预计年复合成长率为 7.3%，到2025年达到 32.2亿美元，到2032年达到 53亿美元。

治疗性血球分离术是一种选择性地从血液中清除有害物质的医疗过程，有助于治疗各种疾病，包括自体免疫疾病、神经系统疾病和血液相关疾病。这些疾病的日益普及以及医疗器材的创新对市场的成长做出了重大贡献。由于技术进步、疾病盛行率上升和精准医疗的日益普及，治疗性血球分离市场预计将大幅扩张。随着领先公司对研发的投入，该产业将在未来几年实现显着成长。

自动化血球分离系统和薄膜过滤技术的采用提高了治疗的效率、安全性和精确度。自体免疫和血液疾病的增加推动了对治疗性血球分离术的需求。越来越多的老年人易患可透过血液白血球分离术治疗的疾病，这推动了市场扩张。医疗保健专业人士对白血球分离术益处的认识不断提高，推动了其广泛应用。

本报告概述了全球治疗性血球分离市场，包括按程序类型、技术、应用、最终用户和地区划分的市场趋势，以及参与市场的公司的竞争动态。

目录

第1章 执行摘要

第2章 市场概览

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE 分析

第3章 定价分析，2019-2023年

第4章 2019年至2032年全球治疗性血球分离市场展望

  • 2019年至2032年全球治疗性血球分离术市场预测，依手术类型、价值（十亿美元）、数量（箱）
  • 2019年至2032年全球治疗性血球分离市场预测，依技术、价值（十亿美元）和数量（箱）
  • 2019年至2032年全球治疗性血球分离市场预测，依应用、价值（十亿美元）和数量（箱）
  • 2019年至2032年全球治疗性血球分离市场预测，依最终用户、价值（十亿美元）、数量（箱）
  • 2019年至2032年全球治疗性血球分离市场预测，依地区、价值（十亿美元）和数量（箱）

第5章 2019年至2032年北美治疗性血球分离市场展望

第6章 2019年至2032年欧洲治疗性血球分离市场展望

第7章 2019-2032年亚太地区治疗性血球分离市场展望

第8章 2019-2032年亚太地区治疗性血球分离市场展望

第9章 2019-2032年中东与非洲治疗性血球分离市场展望

第10章 竞争格局

  • 按手术类型和技术划分的热图
  • 2024年公司市场占有率分析
  • 竞争资讯中心
  • 公司简介
    • Asahi Kasei Medical Co.
    • Haemonetics Corporation
    • Miltenyi Biotec
    • Cerus Corporation
    • Terumo BCT Inc.
    • Fresenius Kabi USA
    • Terumo BCT
    • B. Braun Melsungen AG
    • Nikkiso Co. Ltd.
    • Medica S.p.A.
    • Baxter Healthcare Corporation
    • Kawasumi Laboratories Inc.
    • Therakos Incorporation

第11章 附录

简介目录

The therapeutic apheresis market is on track for remarkable expansion, propelled by advancements in medical technology and the growing integration of precision medicine. With an anticipated CAGR of 7.3%, the market is projected to reach USD 3.22 billion by 2025 and further increase to USD 5.30 billion by 2032.

Market Overview

Therapeutic apheresis is a medical process that selectively removes harmful substances from the bloodstream, aiding in the treatment of various conditions such as autoimmune disorders, neurological ailments, and blood-related diseases. The increasing prevalence of these conditions, alongside innovations in medical equipment, is significantly contributing to market growth. The therapeutic apheresis market is set for significant expansion, driven by technological advancements, rising disease prevalence, and growing adoption of precision medicine. With major players investing in research and development, the industry is poised for transformative growth in the coming years.

Key Market Drivers

  • Advancements in Technology: The adoption of automated apheresis systems and membrane-based filtration technologies has enhanced efficiency, safety, and precision in treatment.
  • Increasing Disease Incidence: Rising cases of autoimmune and hematologic conditions are driving the demand for therapeutic apheresis procedures.
  • Aging Population: The increasing number of elderly individuals, who are more vulnerable to diseases treatable with apheresis, is fostering market expansion.
  • Growing Awareness: Greater recognition among healthcare professionals regarding the benefits of apheresis is facilitating its widespread adoption.

Emerging Business Opportunities

  • Integration into Precision Medicine: The use of therapeutic apheresis in personalized treatment plans is gaining momentum.
  • Diversification of Applications: Beyond its traditional use in hematology and neurology, apheresis is being explored for applications in oncology and rare genetic conditions.
  • Collaborative Growth: Strategic partnerships between healthcare providers, research institutions, and industry stakeholders are driving innovation and market penetration.

Regional Market Trends

  • North America: Expected to maintain the largest share, supported by advanced healthcare infrastructure, high spending on medical treatments, and rapid technological adoption.
  • Asia Pacific: Forecasted to witness the fastest growth due to increasing healthcare investments and rising awareness, especially in China and Japan.
  • Europe: A well-regulated healthcare industry continues to provide steady market expansion.
  • Other Regions (Latin America, , Middle East & Africa): Increasing demand for advanced healthcare solutions is spurring growth in these markets.

Leading Market Participants

Key companies are focusing on research, innovation, and geographical expansion to solidify their market presence. Major players include:

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Recent Industry Developments

  • New Partnership: Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics to develop a novel therapeutic apheresis treatment for acute kidney injury (AKI).
  • Investment in Innovation: NHS England has approved Terumo's Spectra Optia Apheresis System for treating sickle cell disease, significantly increasing its adoption across various institutions.

Market Segmentation

By Procedure Type:

  • Therapeutic Plasma Exchange (TPE)
  • Red Blood Cell Exchange (RBCX)
  • Cellular Depletions

By Technology:

  • Centrifugation
  • Membrane Filtration

By Application:

  • Hematology
  • Neurology
  • Nephrology
  • Rheumatology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Blood Banks
  • Specialty Clinics

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Therapeutic Apheresis Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Procedure Type, 2019 - 2023
  • 3.2. Prominent Factor Affecting Therapeutic Apheresis Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 4.1. Global Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 4.1.1.2. Red Blood Cell Exchange (RBCX)
      • 4.1.1.3. Cellular Depletions
  • 4.2. Global Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Centrifugation
      • 4.2.1.2. Membrane filtration
  • 4.3. Global Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hematology
      • 4.3.1.2. Neurology
      • 4.3.1.3. Nephrology
      • 4.3.1.4. Rheumatology
      • 4.3.1.5. Oncology
      • 4.3.1.6. Others
  • 4.4. Global Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Blood banks
      • 4.4.1.3. Specialty clinics
  • 4.5. Global Therapeutic Apheresis Market Outlook, by Region, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. North America
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia Pacific
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East & Africa

5. North America Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 5.1. North America sTherapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 5.1.1.2. Red Blood Cell Exchange (RBCX)
      • 5.1.1.3. Cellular Depletions
  • 5.2. North America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Centrifugation
      • 5.2.1.2. Membrane filtration
  • 5.3. North America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hematology
      • 5.3.1.2. Neurology
      • 5.3.1.3. Nephrology
      • 5.3.1.4. Rheumatology
      • 5.3.1.5. Oncology
      • 5.3.1.6. Others
  • 5.4. North America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Blood banks
      • 5.4.1.3. Specialty clinics
    • 5.4.2. Attractiveness Analysis
  • 5.5. North America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. U.S. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.2. U.S. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.3. U.S. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.4. U.S. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.5. Canada Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.6. Canada Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.7. Canada Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.8. Canada Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

6. Europe Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 6.1. Europe Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 6.1.1.2. Red Blood Cell Exchange (RBCX)
      • 6.1.1.3. Cellular Depletions
  • 6.2. Europe Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Centrifugation
      • 6.2.1.2. Membrane filtration
  • 6.3. Europe Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hematology
      • 6.3.1.2. Neurology
      • 6.3.1.3. Nephrology
      • 6.3.1.4. Rheumatology
      • 6.3.1.5. Oncology
      • 6.3.1.6. Others
  • 6.4. Europe Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Blood banks
      • 6.4.1.3. Specialty clinics
    • 6.4.2. Attractiveness Analysis
  • 6.5. Europe Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. Germany Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.2. Germany Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.3. Germany Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.4. Germany Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.5. U.K. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.6. U.K. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.7. U.K. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.8. U.K. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.9. France Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.10. France Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.11. France Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.12. France Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.13. Italy Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.14. Italy Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.15. Italy Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.16. Italy Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.17. Turkey Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.18. Turkey Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.19. Turkey Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.20. Turkey Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.21. Russia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.22. Russia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.23. Russia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.24. Russia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.25. Rest of Europe Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.26. Rest of Europe Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.27. Rest of Europe Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.28. Rest of Europe Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

7. Asia Pacific Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 7.1.1.2. Red Blood Cell Exchange (RBCX)
      • 7.1.1.3. Cellular Depletions
  • 7.2. Asia Pacific Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Centrifugation
      • 7.2.1.2. Membrane filtration
  • 7.3. Asia Pacific Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hematology
      • 7.3.1.2. Neurology
      • 7.3.1.3. Nephrology
      • 7.3.1.4. Rheumatology
      • 7.3.1.5. Oncology
      • 7.3.1.6. Others
  • 7.4. Asia Pacific Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Blood banks
      • 7.4.1.3. Specialty clinics
    • 7.4.2. Attractiveness Analysis
  • 7.5. Asia Pacific Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. China Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.2. China Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.3. China Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.4. China Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.5. Japan Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.6. Japan Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.7. Japan Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.8. Japan Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.9. South Korea Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.10. South Korea Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.11. South Korea Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.12. South Korea Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.13. India Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.14. India Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.15. India Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.16. India Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.17. Southeast Asia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.18. Southeast Asia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.19. Southeast Asia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.20. Southeast Asia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.21. Rest of Asia Pacific Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.22. Rest of Asia Pacific Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.23. Rest of Asia Pacific Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.24. Rest of Asia Pacific Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

8. Latin America Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 8.1. Latin America Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 8.1.1.2. Red Blood Cell Exchange (RBCX)
      • 8.1.1.3. Cellular Depletions
  • 8.2. Latin America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Centrifugation
      • 8.2.1.2. Membrane filtration
  • 8.3. Latin America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hematology
      • 8.3.1.2. Neurology
      • 8.3.1.3. Nephrology
      • 8.3.1.4. Rheumatology
      • 8.3.1.5. Oncology
      • 8.3.1.6. Others
  • 8.4. Latin America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Blood banks
      • 8.4.1.3. Specialty clinics
    • 8.4.2. Attractiveness Analysis
  • 8.5. Latin America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.2. Brazil Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.3. Brazil Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.4. Brazil Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.5. Mexico Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.6. Mexico Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.7. Mexico Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.8. Mexico Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.9. Argentina Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.10. Argentina Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.11. Argentina Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.12. Argentina Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.13. Rest of Latin America Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.14. Rest of Latin America Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.15. Rest of Latin America Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.16. Rest of Latin America Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

9. Middle East & Africa Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 9.1.1.2. Red Blood Cell Exchange (RBCX)
      • 9.1.1.3. Cellular Depletions
  • 9.2. Middle East & Africa Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Centrifugation
      • 9.2.1.2. Membrane filtration
  • 9.3. Middle East & Africa Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hematology
      • 9.3.1.2. Neurology
      • 9.3.1.3. Nephrology
      • 9.3.1.4. Rheumatology
      • 9.3.1.5. Oncology
      • 9.3.1.6. Others
  • 9.4. Middle East & Africa Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Blood banks
      • 9.4.1.3. Specialty clinics
    • 9.4.2. Attractiveness Analysis
  • 9.5. Middle East & Africa Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1. Key Highlights
      • 9.5.1.1. GCC Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.2. GCC Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.3. GCC Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.4. GCC Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.5. South Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.6. South Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.7. South Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.8. South Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.9. Egypt Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.10. Egypt Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.11. Egypt Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.12. Egypt Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.13. Nigeria Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.14. Nigeria Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.15. Nigeria Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.16. Nigeria Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.17. Rest of Middle East & Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.18. Rest of Middle East & Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.19. Rest of Middle East & Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.20. Rest of Middle East & Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Procedure Type vs by Technology Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Asahi Kasei Medical Co.
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Haemonetics Corporation
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Miltenyi Biotec
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Cerus Corporation
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Terumo BCT Inc.
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Fresenius Kabi USA
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Terumo BCT
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. B. Braun Melsungen AG
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Nikkiso Co. Ltd.
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Medica S.p.A.
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. Baxter Healthcare Corporation
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Product Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development
    • 10.4.12. Kawasumi Laboratories Inc.
      • 10.4.12.1. Company Overview
      • 10.4.12.2. Product Portfolio
      • 10.4.12.3. Financial Overview
      • 10.4.12.4. Business Strategies and Development
    • 10.4.13. Therakos Incorporation
      • 10.4.13.1. Company Overview
      • 10.4.13.2. Product Portfolio
      • 10.4.13.3. Financial Overview
      • 10.4.13.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations